Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site

Agniswamy, Johnson; Kneller, Daniel W.; Ghosh, Arun K.; Weber, Irene T.

doi:10.1016/j.bbrc.2021.05.094

Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site

Journal Article · 01 August 2021 · Biochem. Biophys. Res. Commun.

DOI:https://doi.org/10.1016/j.bbrc.2021.05.094· OSTI ID:1797466

Agniswamy, Johnson; Kneller, Daniel W.; Ghosh, Arun K.; Weber, Irene T.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH); UNIVERSITY

OSTI ID:: 1797466

Journal Information:: Biochem. Biophys. Res. Commun., Vol. 566

Country of Publication:: United States

Language:: ENGLISH

References (35)

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315 Lederman, M. M.; Connick, E.; Landay, A. Journal of Infectious Diseases, Vol. 178, Issue 1 https://doi.org/10.1086/515591	journal	July 1998
The Survival Benefits of AIDS Treatment in the United States Walensky, Rochelle P.; Paltiel, A. David; Losina, Elena The Journal of Infectious Diseases, Vol. 194, Issue 1 https://doi.org/10.1086/505147	journal	July 2006
Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population Bhaskaran, Krishnan JAMA, Vol. 300, Issue 1 https://doi.org/10.1001/jama.300.1.51	journal	July 2008
Current status and prospects of HIV treatment Cihlar, Tomas; Fordyce, Marshall Current Opinion in Virology, Vol. 18 https://doi.org/10.1016/j.coviro.2016.03.004	journal	June 2016
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection Riddler, Sharon A.; Haubrich, Richard; DiRienzo, A. Gregory New England Journal of Medicine, Vol. 358, Issue 20 https://doi.org/10.1056/NEJMoa074609	journal	May 2008
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel Saag, Michael S.; Benson, Constance A.; Gandhi, Rajesh T. JAMA, Vol. 320, Issue 4 https://doi.org/10.1001/jama.2018.8431	journal	July 2018
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains Tie, Yunfeng; Boross, Peter I.; Wang, Yuan-Fang Journal of Molecular Biology, Vol. 338, Issue 2 https://doi.org/10.1016/j.jmb.2004.02.052	journal	April 2004
Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance Ghosh, Arun K.; Chapsal, Bruno D.; Weber, Irene T. Accounts of Chemical Research, Vol. 41, Issue 1 https://doi.org/10.1021/ar7001232	journal	January 2008
Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor ^§ Surleraux, Dominique L. N. G.; Tahri, Abdellah; Verschueren, Wim G. Journal of Medicinal Chemistry, Vol. 48, Issue 6 https://doi.org/10.1021/jm049560p	journal	March 2005
Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier Dierynck, Inge; De Wit, Mieke; Gustin, Emmanuel Journal of Virology, Vol. 81, Issue 24 https://doi.org/10.1128/JVI.01184-07	journal	October 2007
Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials de Meyer, Sandra; Vangeneugden, Tony; van Baelen, Ben AIDS Research and Human Retroviruses, Vol. 24, Issue 3 https://doi.org/10.1089/aid.2007.0173	journal	March 2008
Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors Louis, J. M.; Aniana, A.; Weber, I. T. Proceedings of the National Academy of Sciences, Vol. 108, Issue 22 https://doi.org/10.1073/pnas.1102278108	journal	May 2011
How Does Darunavir Prevent HIV-1 Protease Dimerization? Huang, Danzhi; Caflisch, Amedeo Journal of Chemical Theory and Computation, Vol. 8, Issue 5 https://doi.org/10.1021/ct300032r	journal	April 2012
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK El Bouzidi, Kate; White, Ellen; Mbisa, Jean L. Journal of Antimicrobial Chemotherapy, Vol. 71, Issue 12 https://doi.org/10.1093/jac/dkw343	journal	September 2016
Global HIV Antiretroviral Drug Resistance Godfrey, Catherine; Thigpen, Michael C.; Crawford, Keith W. The Journal of Infectious Diseases, Vol. 216, Issue suppl_9 https://doi.org/10.1093/infdis/jix137	journal	June 2017
Design, Synthesis, and X-ray Structure of Substituted Bis-tetrahydrofuran (Bis-THF)-Derived Potent HIV-1 Protease Inhibitors Ghosh, Arun K.; Martyr, Cuthbert D.; Steffey, Melinda ACS Medicinal Chemistry Letters, Vol. 2, Issue 4 https://doi.org/10.1021/ml100289m	journal	January 2011
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency Aoki, Manabu; Hayashi, Hironori; Rao, Kalapala Venkateswara eLife, Vol. 6 https://doi.org/10.7554/eLife.28020	journal	October 2017
Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants Ghosh, Arun K.; Rao, Kalapala Venkateswara; Nyalapatla, Prasanth R. ChemMedChem, Vol. 13, Issue 8 https://doi.org/10.1002/cmdc.201700824	journal	March 2018
Identifying representative drug resistant mutants of HIV Yu, Xiaxia; Weber, Irene T.; Harrison, Robert W. BMC Bioinformatics, Vol. 16, Issue Suppl 17 https://doi.org/10.1186/1471-2105-16-S17-S1	journal	January 2015
Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme Park, Joon H.; Sayer, Jane M.; Aniana, Annie Biochemistry, Vol. 55, Issue 16 https://doi.org/10.1021/acs.biochem.6b00012	journal	April 2016
Highly Drug-Resistant HIV-1 Protease Mutant PRS17 Shows Enhanced Binding to Substrate Analogues Agniswamy, Johnson; Kneller, Daniel W.; Brothers, Rowan ACS Omega, Vol. 4, Issue 5 https://doi.org/10.1021/acsomega.9b00683	journal	May 2019
Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics Agniswamy, Johnson; Louis, John M.; Roche, Julien PLOS ONE, Vol. 11, Issue 12 https://doi.org/10.1371/journal.pone.0168616	journal	December 2016
HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural Rearrangements Agniswamy, Johnson; Shen, Chen-Hsiang; Aniana, Annie Biochemistry, Vol. 51, Issue 13 https://doi.org/10.1021/bi2018317	journal	March 2012
“Wide-Open” 1.3 Å Structure of a Multidrug-Resistant HIV-1 Protease as a Drug Target Martin, Philip; Vickrey, John F.; Proteasa, Gheorghe Structure, Vol. 13, Issue 12 https://doi.org/10.1016/j.str.2005.11.005	journal	December 2005
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997
Likelihood-enhanced fast rotation functions Storoni, Laurent C.; McCoy, Airlie J.; Read, Randy J. Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 3 https://doi.org/10.1107/S0907444903028956	journal	February 2004
Likelihood-enhanced fast translation functions McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C. Acta Crystallographica Section D Biological Crystallography, Vol. 61, Issue 4 https://doi.org/10.1107/S0907444905001617	journal	March 2005
Refinement of Macromolecular Structures by the Maximum-Likelihood Method Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3 https://doi.org/10.1107/S0907444996012255	journal	May 1997
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database Shafer, R. W.; Stevenson, D.; Chan, B. Nucleic Acids Research, Vol. 27, Issue 1 https://doi.org/10.1093/nar/27.1.348	journal	January 1999
HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance Rhee, Soo-Yon; Taylor, Jonathan; Fessel, W. Jeffrey Antimicrobial Agents and Chemotherapy, Vol. 54, Issue 10 https://doi.org/10.1128/AAC.00574-10	journal	October 2010
Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy Kantor, Rami; Fessel, W. Jeffrey; Zolopa, Andrew R. Antimicrobial Agents and Chemotherapy, Vol. 46, Issue 4 https://doi.org/10.1128/AAC.46.4.1086-1092.2002	journal	April 2002
Analysis of HIV-1 CRF_01 A/E Protease Inhibitor Resistance: Structural Determinants for Maintaining Sensitivity and Developing Resistance to Atazanavir Clemente, José C.; Coman, Roxana M.; Thiaville, Michele M. Biochemistry, Vol. 45, Issue 17 https://doi.org/10.1021/bi051886s	journal	April 2006
Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations Shahriar, Rajin; Rhee, Soo-Yon; Liu, Tommy F. Antimicrobial Agents and Chemotherapy, Vol. 53, Issue 11 https://doi.org/10.1128/AAC.00592-09	journal	November 2009
Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 A resolution crystal structures of HIV-1 protease mutants with substrate analogs Tie, Yunfeng; Boross, Peter I.; Wang, Yuan-Fang FEBS Journal, Vol. 272, Issue 20 https://doi.org/10.1111/j.1742-4658.2005.04923.x	journal	October 2005

Similar Records

Design, Synthesis, and X-ray Structure of Substituted Bis-tetrahydrofuran (Bis-THF)-Derived Potent HIV-1 Protease Inhibitors

Journal Article · 2012 · ACS Medicinal Chemistry Letters · OSTI ID:1043724

Ghosh, Arun K; Martyr, Cuthbert D; Steffey, Melinda; +5 more

Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20

Journal Article · 2015 · Journal of Medicinal Chemistry · OSTI ID:1213713

Agniswamy, Johnson; Louis, John M.; Shen, Chen-Hsiang; +3 more

A Conserved Hydrogen-Bonding Network of P2 bis-Tetrahydrofuran-Containing HIV-1 Protease Inhibitors (PIs) with a Protease Active-Site Amino Acid Backbone Aids in Their Activity against PI-Resistant HIV

Journal Article · 2014 · Antimicrob. Agents Ch. · OSTI ID:1140240

Yedidi, Ravikiran S.; Garimella, Harisha; Aoki, Manabu; +12 more

Novel HIV PR inhibitors with C4-substituted bis-THF and bis-fluoro-benzyl target the two active site

Citation Formats

References (35)

Similar Records

Related Subjects